title: Recent advances in liposome technologies and their applications for systemic gene delivery.
abstract: The recent clinical successes experienced by liposomal drug delivery systems stem from the ability to produce well-defined liposomes that can be composed of a wide variety of lipids, have high drug-trapping efficiencies and have a narrow size distribution, averaging less than 100 nm in diameter. Agents that prolong the circulation lifetime of liposomes, enhance the delivery of liposomal drugs to specific target cells, or enhance the ability of liposomes to deliver drugs intracellularly can be incorporated to further increase the therapeutic activity. The physical and chemical requirements for optimum liposome drug delivery systems will likely apply to lipid-based gene delivery systems. As a result, the development of liposomal delivery systems for systemic gene delivery should follow similar strategies.
authors.affiliation: Inex Pharmaceuticals Corporation, 1779 West 75th Street, Vancouver, BC, V6P 6P2, Canada
authors.initials: PR
authors.lastname: Cullis
authors.initials: A
authors.lastname: Chonn